Pharma major plummets over 10% after third trial disappointment in a week
- Posted on September 8, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Pharma major plummets over 10% after third trial disappointment in a week
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
